Liver nodule ultrasound test for cancer patients
Part of Cancer clinical trials.
This study uses a special ultrasound with contrast dye to look at liver nodules seen on MRI in people who have had cancer. The goal is to see if the ultrasound can better tell if these nodules are cancerous.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have had cancer before
- An MRI showed you have a liver nodule that is at least 1 cm (10 mm) across
- You are able to have an MRI and an ultrasound with contrast dye
- You have not had a large part of your liver removed or a liver transplant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at whether special features seen on contrast-enhanced ultrasound can help doctors better classify liver nodules using a system called LI-RADS. It’s for people at high risk for liver cancer who have recent imaging and clear tissue diagnosis.
This trial compares two types of scans to see which detects liver cancer better in people at high risk. You would receive either an MRI with contrast or an ultrasound every 6 months to monitor for liver cancer.
This study uses ultrasound images to help tell the difference between benign (non-cancerous) and malignant (cancerous) liver tumors without needing a needle biopsy. If you are 18–70, have a liver tumor visible on ultrasound, and are planning a biopsy or surgery to confirm the diagnosis, you may be able to join.
This trial uses a special, high-detail ultrasound to get clearer images of liver tumors. It may help doctors better understand your tumor without extra procedures.
This study tests a new ultrasound technique to catch liver cancer sooner. If you have regular imaging checks for liver cancer or are getting an MRI for a liver spot, you may be able to join.
This study compares a shorter, non-contrast MRI and ultrasound to monitor for liver cancer in people with cirrhosis whose ultrasound images aren’t clear enough. It aims to see which method works better and may help you get safer, more reliable follow-up.
Hear when a new Hepatic Malignant Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.